Becton Dickinson andNYSE: BDX

BROWNSVILLE, Texas , Nov. 20, 2024 /PRNewswire/ -- A first of its kind Human Papillomavirus (HPV) self-collection screening pilot program aimed at improving cervical cancer screening in underserved communities has officially launched in Texas. HPV is the cause of virtually all cervical cancers.

Becton Dickinson (BDX) is likely to do better than the market because it shows stronger growth in its financial performance.

Becton Dickinson (BDX) reported quarterly earnings of $3.81 per share, which is higher than the Zacks Consensus Estimate of $3.77 per share. This is an increase compared to earnings of $3.42 per share from the same period last year.

Investors interested in the Medical - Dental Supplies sector may want to look at Becton Dickinson (BDX) or Merit Medical (MMSI). The question is, which of these two stocks provides better value for money for investors at this time?

Becton, Dickinson and Company (NYSE:BDX) will hold its Q4 2024 Earnings Conference Call on November 7, 2024, at 8:00 AM ET. Key company participants include Greg Rodetis, Tom Polen, Chris DelOrefice, and Mike Garrison, along with various conference call participants from major financial institutions. The call is being recorded and will be available for replay on BD's Investor Relations website or by phone for both domestic and international callers.

It is anticipated that the strong demand for BD's products will boost revenues in the fourth quarter of the fiscal year.

To better understand how Becton Dickinson (BDX) might perform in the quarter ending September 2024, it's important to look past Wall Street's basic profit and loss predictions. Instead, focus on the estimates for some of the company's important metrics. This will give you a clearer picture of its potential performance.

In my newest article, I share forecasts for upcoming dividend increases from companies known for their long-term growth in dividends. I anticipate that 13 companies will reveal their annual increases in early November, with Automatic Data Processing, Roper Technologies, and Snap-on expected to have double-digit raises. Last month, investors enjoyed significant increases of over 10% from Brown & Brown, Visa, and RPM.

BD has introduced the BD Intraosseous Vascular Access System, designed to provide rapid vascular access in emergency medical situations. This system aims to improve care during critical times.